Breaking Finance News

Insulet Corporation (NASDAQ:PODD) target price raised to $46.00, issued a report today by B. Riley

Insulet Corporation (NASDAQ:PODD) had its price target upped to $46.00 by B. Riley in a report released Sunday October 02, 2016. The new stock price target implies a possible upside of 0.12% from the company's most recent stock price close.

On 9/27/2016, B. Riley released a statement for Insulet Corporation (NASDAQ:PODD) bumped up the target price from $0.00 to $46.00 that suggested an upside of 0.06%.

Displaying a price of $40.94, Insulet Corporation (NASDAQ:PODD) traded 3.57% higher on the day. With the last stock close price up 16.95% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time. The company has recorded a 50-day moving average of $42.87 and a 200-day moving average of $35.01. Volume of trade was up over the average, with 797,877 shares of PODD changing hands over the typical 562,727

Performance Chart

Insulet Corporation (NASDAQ:PODD)

With a total market value of $0, Insulet Corporation has with a one year low of $23.94 and a one year high of $45.60 .

General Company Details For Insulet Corporation (NASDAQ:PODD)

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The OmniPod System consists of the OmniPod, a small, self-adhesive disposable tubeless OmniPod device, which is worn on the body for approximately three days at a time and its wireless handheld Personal Diabetes Manager (PDM). The Company purchases OmniPods pursuant to its agreement with Flextronics. It also partners with pharmaceutical and biotechnology companies to tailor the OmniPod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas. It sells the OmniPod System and other diabetes management supplies in the United States through direct sales to customers or through its distribution partners. The Company purchases OmniPods pursuant to its agreement with Flextronics. The OmniPod System is available in Europe, Canada and Israel.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *